1. Shareholders' Meeting Resolution Date: June 17, 2026
2. Names and Titles of Directors Permitted to Engage in Competitive Activities: - Director: Chen Feng-Ming, representative of Teyong Investment Co., Ltd. - Director: Chen Chang-Hao, representative of Taiwei Biotech Co., Ltd. - Director: Li Mao-Sheng, representative of Maosheng Investment Co., Ltd.
3. Permitted Competitive Activities: Projects identical or similar to the company's business scope
4. Duration of Permitted Competitive Activities: During the period of serving as directors of the company
5. Resolution Outcome (Voting Results under Article 209 of the Company Act): Approved as proposed through voting.
6. Directors Engaging in Competitive Activities Related to Mainland China-based Businesses (Enter 'Not Applicable' if not applicable): Not Applicable
7. Company Name and Position Held in Such Mainland China-based Business: Not Applicable
8. Address of Such Mainland China-based Business: Not Applicable
9. Business Scope of Such Mainland China-based Business: Not Applicable
10. Impact on the Company's Financial and Business Operations: Not Applicable
11. If Directors Have Invested in Such Mainland China-based Business, Investment Amount and Shareholding Ratio: Not Applicable
12. Other Matters to Be Disclosed: None
FACT BOX
- Source: PR Times
- Category: News